Stay informed with the latest updates for the inheritable blood disorders community. Industry First Patient Dosed with Hemophilia Gene Therapy Candidate ASC618 Dec 4, 2023 Industry Sernova Receives Dual FDA Designations for Investigational Hemophilia… Nov 29, 2023 Industry Investigational T-Cell Therapy for Hemophilia A… Oct 12, 2023 Industry New Trial Data Shows ALTUVIIIO™ Prophylaxis Effective in Children Jul 3, 2023 Industry Hemophilia A Gene Therapy Product Receives U.S. FDA Approval Jun 30, 2023 Industry First Hemophilia B Patient Dosed with Gene Therapy Product Jun 20, 2023 Industry Pfizer Highlights Phase 3 Trial Results of Marstacimab May 31, 2023 Industry FDA Requests Additional Information on Concizumab from Novo Nordisk May 5, 2023 Industry Sanofi Announces Publication of Two Phase 3 Fitusiran Trials Apr 6, 2023 Industry BioMarin Announces FDA’s Extended Review of Investigational… Mar 10, 2023 Industry uniQure Announces Published Trial Results for Approved Gene Therapy Feb 27, 2023 Industry FDA Approves ALTUVIIIO™ for Hemophilia A Patients Feb 24, 2023 Industry Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM Jan 30, 2023 Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program Updates Jan 10, 2023 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
